MightyTIL™
Sarcoma, Head and Neck Cancer, Melanoma
PreclinicalActive
Key Facts
Indication
Sarcoma, Head and Neck Cancer, Melanoma
Phase
Preclinical
Status
Active
Company
About TrAMPoline Pharma
TrAMPoline Pharma is a private, preclinical-stage biotech founded in 2019 and based in Cambridge, MA, with a research facility in Aurora, CO. The company is pioneering next-generation TIL therapies for solid tumors using its patented coR8:Amp™ gene engineering platform, which is designed to boost T cell potency, persistence, and polyclonality. Its lead program, MightyTIL™, has shown superior anti-tumor activity in animal models compared to conventional TILs, positioning it to address the significant unmet need in solid tumors where many immunotherapies fail. The company is led by a seasoned team with deep expertise in immunotherapy and biotech entrepreneurship.
View full company profile